Fenelzine: een vergeten MAO-remmer met een specifiek indicatiegebied

Translated title of the contribution: Phenelzine: A forgotten MAO-inhibitor with specific indication(s)

T. K. Birkenhager*, M. Vegt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


The MAO inhibitor phenelzine is virtually out of use in the Netherlands. In this article the more recent studies concerning phenelzine in atypical depression, major depression and panic disorder, are reviewed. The best established indication for treatment with phenelzine is atypical depression. It is unclear whether phenelzine is more effective than TCA in depression with panic attacks and in elderly depressed patients. Remarkably few comparative studies have been conducted in patients with panic disorder. The side effects produced by phenelzine are less than those of tranylcypromine, but moclobemide is definitely more benign than phenelzine.

Translated title of the contributionPhenelzine: A forgotten MAO-inhibitor with specific indication(s)
Original languageDutch
Pages (from-to)182-194
Number of pages13
JournalTijdschrift voor Psychiatrie
Issue number3
Publication statusPublished - 1994
Externally publishedYes


Dive into the research topics of 'Phenelzine: A forgotten MAO-inhibitor with specific indication(s)'. Together they form a unique fingerprint.

Cite this